Statistics

Total Visits

Views
Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study69

File Visits

Downloads
41131-1808.pdf18

Select a period of time:

Number of views in the range

Views
Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study16

Number of downloads in the range

Downloads
41131-1808.pdf6

Views

Views
September 20253
October 20251
November 20251
December 20252
January 20266
February 20261
March 20262
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • September 2025
    0
  • October 2025
    0
  • November 2025
    0
  • December 2025
    3
  • January 2026
    2
  • February 2026
    1
  • March 2026
    0
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
Brazil3
Colombia1
Ecuador1
Honduras1
 

Top countries by downloads

Downloads
United States5
 

Top cities views

Views
San Jose6
Ashburn1
Brasília1
Caxias do Sul1
Guayaquil1
Macapá1
Manizales1
Miami1
Tegucigalpa1
 

Top cities by downloads

Downloads